Stability Indicating Test Procedure
Stability Indicating Test Procedure
TEST PROCEDURE
SUBMITTED BY
POOJA SINGH
M.PHARM.(1ST SEM)
QUALITY ASSURANCE
INTRODUCTION
Stability indicating test procedure is a method which
differentiate and quantity the active ingredients being
assayed from other active ingredient, excipient,
synthetic impurities & degradation products present in
the dosage form.
Various factors contribute to the nonspecificity of an
assay procedure
1. If dosage form contain two or more active ingredients,
then this may interfere in assay, interference may
occur by excipient like preservative, diluents,
chelating agent, antioxidant etc.
2. Raw material may also introduce impurities in the
form of its starting material & its impurities,
intermediates or by products.
Product non specific also get introduced during its
processing & manufacturing finally degradation or
decomposition products of active ingredients may
arise due to drug-drug interaction, drug excipient
interaction, drug dosage form container-closure
interaction.
Stability Indicating Assay
1.Conventional method
• Low cost
• Simplicity
2. Instrumental method
lesser analysis time & accurate for small amount sample.
Advantage-
Many samples can run simultaneously.
Disadvantage-
b/c volume of sample is very low so inability to use another
identification technique.
degradation products.
Selectively measure both drug and decomposition product.
1.Selective determination of active drug
Example- atropine degradation would be ester hydrolysis
2. Phenazocine HBr
PHENAZOCINE DESPHENETHYL PHENAZOCINE
+
STYRENE
Gas chromatography (as reference method) for methanol
sulphuric acid colorimetric assay for quinesterol, ethinyl
estradiol 3-cyclopentyl ether.
Solubility analysis as a reference method for judging the
CHLORAMPHENICOL
Estimation of decomposition products
2. Stability of hydrochlorthiazide
HYDROCHLORTHIAZIDE 4-AMINO-6-CHLORO,
1-3DISULPHAMIE
FORMALDEHYDE